Amfoterisin B (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Amfoterisin B" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

20doi.org

2^nd place

4^th place

17nih.gov

4^th place

13^th place

12worldcat.org

5^th place

7^th place

10web.archive.org

1^st place

3oxfordjournals.org

1,389^th place

721^st place

3who.int

195^th place

203^rd place

1drugs.com

399^th place

480^th place

1books.google.com

3^rd place

6^th place

1google.ca

838^th place

272^nd place

1mit.edu

415^th place

544^th place

1eucast.org

low place

1toku-e.com

low place

1archive.org

6^th place

2^nd place

1fda.gov

447^th place

792^nd place

1webcitation.org

24^th place

33^rd place

1thefreedictionary.com

614^th place

254^th place

1uwec.edu

low place

1pfizer.com

low place

1utdol.com

low place

archive.org

Slain, Douglas (1999-03-01). "Lipid-Based Amphotericin B for the Treatment of Fungal Infections". Pharmacotherapy. 19 (3): 306–323. doi:10.1592/phco.19.4.306.30934. ISSN 1875-9114.

books.google.com

Walker, S. R. (2012). Trends and Changes in Drug Research and Development (dalam bahasa Inggris). Springer Science & Business Media. hlm. 109. ISBN 9789400926592. Diarsipkan dari versi asli tanggal 2017-09-10.

doi.org

Moen, Marit D.; Lyseng-Williamson, Katherine A.; Scott, Lesley J. (2012-09-17). "Liposomal Amphotericin B". Drugs. 69 (3): 361–392. doi:10.2165/00003495-200969030-00010. ISSN 0012-6667. PMID 19275278.
den Boer, Margriet; Davidson, Robert N. (2006-04-01). "Treatment options for visceral leishmaniasis". Expert Review of Anti-Infective Therapy. 4 (2): 187–197. doi:10.1586/14787210.4.2.187. ISSN 1744-8336. PMID 16597201.
Grace, Eddie; Asbill, Scott; Virga, Kris (November 2015). "Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options". Antimicrobial Agents and Chemotherapy. 59 (11): 6677–6681. doi:10.1128/AAC.01293-15. PMC 4604384 . PMID 26259797.
Hamill, Richard J. (2013-06-01). "Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity". Drugs. 73 (9): 919–934. doi:10.1007/s40265-013-0069-4. ISSN 0012-6667. PMID 23729001.
Dutcher, James D. (1968-10-01). "THe discovery and development of amphotericin b". Chest. 54 (Supplement_1): 296–298. doi:10.1378/chest.54.Supplement_1.296. ISSN 0012-3692.
Maertens, J. A. (2004-03-01). "History of the development of azole derivatives". Clinical Microbiology and Infection. 10: 1–10. doi:10.1111/j.1470-9465.2004.00841.x. ISSN 1469-0691. PMID 14748798.
Clemons, KV; Stevens, DA (April 1998). "Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for Treatment of Systemic Murine Cryptococcosis". Antimicrobial Agents and Chemotherapy. 42 (4): 899–902. doi:10.1128/AAC.42.4.899. PMC 105563 . PMID 9559804.
Botero Aguirre, Juan Pablo; Restrepo Hamid, Alejandra Maria (2015-11-23). "Cochrane Database of Systematic Reviews". Cochrane Database of Systematic Reviews (dalam bahasa Inggris) (11): CD010481. doi:10.1002/14651858.cd010481.pub2. PMID 26595825.
Mistro, Sóstenes; Maciel, Isis de M.; Menezes, Rouseli G. de; Maia, Zuinara P.; Schooley, Robert T.; Badaró, Roberto (2012-06-15). "Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis". Clinical Infectious Diseases. 54 (12): 1774–1777. doi:10.1093/cid/cis290. ISSN 1058-4838. PMID 22491505.
Bennett, John (2000-11-15). "Editorial Response: Choosing Amphotericin B Formulations—Between a Rock and a Hard Place". Clinical Infectious Diseases (dalam bahasa Inggris). 31 (5): 1164–1165. doi:10.1086/317443. ISSN 1058-4838. PMID 11073746.
Slain, Douglas (1999-03-01). "Lipid-Based Amphotericin B for the Treatment of Fungal Infections". Pharmacotherapy. 19 (3): 306–323. doi:10.1592/phco.19.4.306.30934. ISSN 1875-9114.
"Highly Effective oral amphotericin B formulation against murine visceral leishmaniasis". J Infect Dis. 200 (3): 357–360. 2009. doi:10.1086/600105. PMID 19545212.
Pappas, Peter G.; Kauffman, Carol A.; Andes, David; Benjamin, Daniel K.; Calandra, Thierry F.; Edwards, John E.; Filler, Scott G.; Fisher, John F.; Kullberg, Bart-Jan (2009-03-01). "Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 48 (5): 503–535. doi:10.1086/596757. ISSN 1537-6591. PMID 19191635.
Walsh, Thomas J.; Finberg, Robert W.; Arndt, Carola; Hiemenz, John; Schwartz, Cindy; Bodensteiner, David; Pappas, Peter; Seibel, Nita; Greenberg, Richard N. (1999-03-11). "Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia". New England Journal of Medicine. 340 (10): 764–771. doi:10.1056/NEJM199903113401004. ISSN 0028-4793. PMID 10072411.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A.; Lortholary, Olivier (2010-02-01). "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMC 5826644 . PMID 20047480. Diarsipkan dari versi asli tanggal 2016-05-21.
Zietse, R.; Zoutendijk, R.; Hoorn, E. J. (2009). "Fluid, electrolyte and acid–base disorders associated with antibiotic therapy". Nature Reviews Nephrology. 5 (4): 193–202. doi:10.1038/nrneph.2009.17. PMID 19322184.
Mesa-Arango, Ana Cecilia; Scorzoni, Liliana; Zaragoza, Oscar (2012-01-01). "It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug". Fungi and Their Interactions. 3: 286. doi:10.3389/fmicb.2012.00286. PMC 3441194 . PMID 23024638.
O'Keeffe, Joseph; Doyle, Sean; Kavanagh, Kevin (2003-12-01). "Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B". Journal of Pharmacy and Pharmacology. 55 (12): 1629–1633. doi:10.1211/0022357022359. ISSN 2042-7158. PMID 14738588.
Baginski, M.; Czub, J. (2009). "Amphotericin B and Its New Derivatives–Mode of Action". Current Drug Metabolism. 10 (5): 459–69. doi:10.2174/138920009788898019. PMID 19689243.
Vertut-Croquin, Aline; Bolard, Jacques; Chabbert, Marie; Gary-Bobo, Claude (1983). "Differences in the Interaction of the Polyene Antibiotic Amphotericin B with Cholesterol- or Ergosterol-Containing Phospholipid Vesicles. A Circular Dichroism and Permeability Study". Biochemistry. 22 (12): 2939–2944. doi:10.1021/bi00281a024.

drugs.com

"Amphotericin B". The American Society of Health-System Pharmacists. Diarsipkan dari versi asli tanggal 2015-01-01. Diakses tanggal Jan 1, 2015.

eucast.org

"European Committee on Antimicrobial Susceptibility Testing: Antifungal Agents, Breakpoint tables for interpretation of MICs" (PDF). 2015-11-16. Diakses tanggal 2015-11-17.

fda.gov

accessdata.fda.gov

"Drugs@FDA: FDA Approved Drug Products". www.accessdata.fda.gov. Diarsipkan dari versi asli tanggal 2014-09-05. Diakses tanggal 2015-11-03.

google.ca

books.google.ca

Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery (dalam bahasa Inggris). John Wiley & Sons. hlm. 477. ISBN 9783527607495.

mit.edu

wi.mit.edu

Rura, Nicole (2013-10-29). "Understanding the evolution of drug resistance points to novel strategy for developing better antimicrobials". Diarsipkan dari versi asli tanggal 2016-11-15. Diakses tanggal 2016-11-14 – via Whitehead Institute.

nih.gov

ncbi.nlm.nih.gov

Moen, Marit D.; Lyseng-Williamson, Katherine A.; Scott, Lesley J. (2012-09-17). "Liposomal Amphotericin B". Drugs. 69 (3): 361–392. doi:10.2165/00003495-200969030-00010. ISSN 0012-6667. PMID 19275278.
den Boer, Margriet; Davidson, Robert N. (2006-04-01). "Treatment options for visceral leishmaniasis". Expert Review of Anti-Infective Therapy. 4 (2): 187–197. doi:10.1586/14787210.4.2.187. ISSN 1744-8336. PMID 16597201.
Grace, Eddie; Asbill, Scott; Virga, Kris (November 2015). "Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options". Antimicrobial Agents and Chemotherapy. 59 (11): 6677–6681. doi:10.1128/AAC.01293-15. PMC 4604384 . PMID 26259797.
Hamill, Richard J. (2013-06-01). "Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity". Drugs. 73 (9): 919–934. doi:10.1007/s40265-013-0069-4. ISSN 0012-6667. PMID 23729001.
Maertens, J. A. (2004-03-01). "History of the development of azole derivatives". Clinical Microbiology and Infection. 10: 1–10. doi:10.1111/j.1470-9465.2004.00841.x. ISSN 1469-0691. PMID 14748798.
Clemons, KV; Stevens, DA (April 1998). "Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for Treatment of Systemic Murine Cryptococcosis". Antimicrobial Agents and Chemotherapy. 42 (4): 899–902. doi:10.1128/AAC.42.4.899. PMC 105563 . PMID 9559804.
Botero Aguirre, Juan Pablo; Restrepo Hamid, Alejandra Maria (2015-11-23). "Cochrane Database of Systematic Reviews". Cochrane Database of Systematic Reviews (dalam bahasa Inggris) (11): CD010481. doi:10.1002/14651858.cd010481.pub2. PMID 26595825.
Mistro, Sóstenes; Maciel, Isis de M.; Menezes, Rouseli G. de; Maia, Zuinara P.; Schooley, Robert T.; Badaró, Roberto (2012-06-15). "Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis". Clinical Infectious Diseases. 54 (12): 1774–1777. doi:10.1093/cid/cis290. ISSN 1058-4838. PMID 22491505.
Bennett, John (2000-11-15). "Editorial Response: Choosing Amphotericin B Formulations—Between a Rock and a Hard Place". Clinical Infectious Diseases (dalam bahasa Inggris). 31 (5): 1164–1165. doi:10.1086/317443. ISSN 1058-4838. PMID 11073746.
"Highly Effective oral amphotericin B formulation against murine visceral leishmaniasis". J Infect Dis. 200 (3): 357–360. 2009. doi:10.1086/600105. PMID 19545212.
Pappas, Peter G.; Kauffman, Carol A.; Andes, David; Benjamin, Daniel K.; Calandra, Thierry F.; Edwards, John E.; Filler, Scott G.; Fisher, John F.; Kullberg, Bart-Jan (2009-03-01). "Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 48 (5): 503–535. doi:10.1086/596757. ISSN 1537-6591. PMID 19191635.
Walsh, Thomas J.; Finberg, Robert W.; Arndt, Carola; Hiemenz, John; Schwartz, Cindy; Bodensteiner, David; Pappas, Peter; Seibel, Nita; Greenberg, Richard N. (1999-03-11). "Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia". New England Journal of Medicine. 340 (10): 764–771. doi:10.1056/NEJM199903113401004. ISSN 0028-4793. PMID 10072411.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A.; Lortholary, Olivier (2010-02-01). "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMC 5826644 . PMID 20047480. Diarsipkan dari versi asli tanggal 2016-05-21.
Zietse, R.; Zoutendijk, R.; Hoorn, E. J. (2009). "Fluid, electrolyte and acid–base disorders associated with antibiotic therapy". Nature Reviews Nephrology. 5 (4): 193–202. doi:10.1038/nrneph.2009.17. PMID 19322184.
Mesa-Arango, Ana Cecilia; Scorzoni, Liliana; Zaragoza, Oscar (2012-01-01). "It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug". Fungi and Their Interactions. 3: 286. doi:10.3389/fmicb.2012.00286. PMC 3441194 . PMID 23024638.
O'Keeffe, Joseph; Doyle, Sean; Kavanagh, Kevin (2003-12-01). "Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B". Journal of Pharmacy and Pharmacology. 55 (12): 1629–1633. doi:10.1211/0022357022359. ISSN 2042-7158. PMID 14738588.
Baginski, M.; Czub, J. (2009). "Amphotericin B and Its New Derivatives–Mode of Action". Current Drug Metabolism. 10 (5): 459–69. doi:10.2174/138920009788898019. PMID 19689243.

oxfordjournals.org

cid.oxfordjournals.org

Mistro, Sóstenes; Maciel, Isis de M.; Menezes, Rouseli G. de; Maia, Zuinara P.; Schooley, Robert T.; Badaró, Roberto (2012-06-15). "Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis". Clinical Infectious Diseases. 54 (12): 1774–1777. doi:10.1093/cid/cis290. ISSN 1058-4838. PMID 22491505.
Bennett, John (2000-11-15). "Editorial Response: Choosing Amphotericin B Formulations—Between a Rock and a Hard Place". Clinical Infectious Diseases (dalam bahasa Inggris). 31 (5): 1164–1165. doi:10.1086/317443. ISSN 1058-4838. PMID 11073746.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A.; Lortholary, Olivier (2010-02-01). "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMC 5826644 . PMID 20047480. Diarsipkan dari versi asli tanggal 2016-05-21.

pfizer.com

Pfizer. Amphocin. Accessed at "Archived copy" (PDF). Diarsipkan dari versi asli (PDF) tanggal 2011-04-19. Diakses tanggal 2010-02-18. on Feb 18 2010.

thefreedictionary.com

medical-dictionary.thefreedictionary.com

"Shake and Bake". TheFreeDictionary.com. Diakses tanggal 2016-12-09.

toku-e.com

antibiotics.toku-e.com

"Index | The Antimicrobial Index Knowledgebase - TOKU-E". antibiotics.toku-e.com. Diarsipkan dari versi asli tanggal 2015-11-09. Diakses tanggal 2015-11-17.

utdol.com

Drew, R. Pharmacology of amphotericin B. Uptodate. Sep 2009. Accessed at http://www.utdol.com/online/content/topic.do?topicKey=antibiot/4619&selectedTitle=2~150&source=search_result^{[pranala nonaktif permanen]} on Feb 18 2010.

uwec.edu

chem.uwec.edu

Hartsel, Scott. "Studies on Amphotericin B" (PDF). Diarsipkan (PDF) dari versi asli tanggal 20 December 2016. Diakses tanggal 8 December 2016.

web.archive.org

Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases (PDF). World Health Organization. March 2010. hlm. 55, 88, 186. ISBN 9789241209496. Diarsipkan (PDF) dari versi asli tanggal 2017-03-15.
"Amphotericin B". The American Society of Health-System Pharmacists. Diarsipkan dari versi asli tanggal 2015-01-01. Diakses tanggal Jan 1, 2015.
WHO Model Formulary 2008 (PDF). World Health Organization. 2009. hlm. 145. ISBN 9789241547659. Diarsipkan (PDF) dari versi asli tanggal 13 December 2016. Diakses tanggal 8 December 2016.
Walker, S. R. (2012). Trends and Changes in Drug Research and Development (dalam bahasa Inggris). Springer Science & Business Media. hlm. 109. ISBN 9789400926592. Diarsipkan dari versi asli tanggal 2017-09-10.
"WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Diarsipkan (PDF) dari versi asli tanggal 13 December 2016. Diakses tanggal 8 December 2016.
Rura, Nicole (2013-10-29). "Understanding the evolution of drug resistance points to novel strategy for developing better antimicrobials". Diarsipkan dari versi asli tanggal 2016-11-15. Diakses tanggal 2016-11-14 – via Whitehead Institute.
"Index | The Antimicrobial Index Knowledgebase - TOKU-E". antibiotics.toku-e.com. Diarsipkan dari versi asli tanggal 2015-11-09. Diakses tanggal 2015-11-17.
Hartsel, Scott. "Studies on Amphotericin B" (PDF). Diarsipkan (PDF) dari versi asli tanggal 20 December 2016. Diakses tanggal 8 December 2016.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A.; Lortholary, Olivier (2010-02-01). "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMC 5826644 . PMID 20047480. Diarsipkan dari versi asli tanggal 2016-05-21.
Pfizer. Amphocin. Accessed at "Archived copy" (PDF). Diarsipkan dari versi asli (PDF) tanggal 2011-04-19. Diakses tanggal 2010-02-18. on Feb 18 2010.

webcitation.org

"Drugs@FDA: FDA Approved Drug Products". www.accessdata.fda.gov. Diarsipkan dari versi asli tanggal 2014-09-05. Diakses tanggal 2015-11-03.

who.int

apps.who.int

Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases (PDF). World Health Organization. March 2010. hlm. 55, 88, 186. ISBN 9789241209496. Diarsipkan (PDF) dari versi asli tanggal 2017-03-15.
WHO Model Formulary 2008 (PDF). World Health Organization. 2009. hlm. 145. ISBN 9789241547659. Diarsipkan (PDF) dari versi asli tanggal 13 December 2016. Diakses tanggal 8 December 2016.

who.int

"WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Diarsipkan (PDF) dari versi asli tanggal 13 December 2016. Diakses tanggal 8 December 2016.

worldcat.org

Moen, Marit D.; Lyseng-Williamson, Katherine A.; Scott, Lesley J. (2012-09-17). "Liposomal Amphotericin B". Drugs. 69 (3): 361–392. doi:10.2165/00003495-200969030-00010. ISSN 0012-6667. PMID 19275278.
den Boer, Margriet; Davidson, Robert N. (2006-04-01). "Treatment options for visceral leishmaniasis". Expert Review of Anti-Infective Therapy. 4 (2): 187–197. doi:10.1586/14787210.4.2.187. ISSN 1744-8336. PMID 16597201.
Hamill, Richard J. (2013-06-01). "Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity". Drugs. 73 (9): 919–934. doi:10.1007/s40265-013-0069-4. ISSN 0012-6667. PMID 23729001.
Dutcher, James D. (1968-10-01). "THe discovery and development of amphotericin b". Chest. 54 (Supplement_1): 296–298. doi:10.1378/chest.54.Supplement_1.296. ISSN 0012-3692.
Maertens, J. A. (2004-03-01). "History of the development of azole derivatives". Clinical Microbiology and Infection. 10: 1–10. doi:10.1111/j.1470-9465.2004.00841.x. ISSN 1469-0691. PMID 14748798.
Mistro, Sóstenes; Maciel, Isis de M.; Menezes, Rouseli G. de; Maia, Zuinara P.; Schooley, Robert T.; Badaró, Roberto (2012-06-15). "Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis". Clinical Infectious Diseases. 54 (12): 1774–1777. doi:10.1093/cid/cis290. ISSN 1058-4838. PMID 22491505.
Bennett, John (2000-11-15). "Editorial Response: Choosing Amphotericin B Formulations—Between a Rock and a Hard Place". Clinical Infectious Diseases (dalam bahasa Inggris). 31 (5): 1164–1165. doi:10.1086/317443. ISSN 1058-4838. PMID 11073746.
Slain, Douglas (1999-03-01). "Lipid-Based Amphotericin B for the Treatment of Fungal Infections". Pharmacotherapy. 19 (3): 306–323. doi:10.1592/phco.19.4.306.30934. ISSN 1875-9114.
Pappas, Peter G.; Kauffman, Carol A.; Andes, David; Benjamin, Daniel K.; Calandra, Thierry F.; Edwards, John E.; Filler, Scott G.; Fisher, John F.; Kullberg, Bart-Jan (2009-03-01). "Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 48 (5): 503–535. doi:10.1086/596757. ISSN 1537-6591. PMID 19191635.
Walsh, Thomas J.; Finberg, Robert W.; Arndt, Carola; Hiemenz, John; Schwartz, Cindy; Bodensteiner, David; Pappas, Peter; Seibel, Nita; Greenberg, Richard N. (1999-03-11). "Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia". New England Journal of Medicine. 340 (10): 764–771. doi:10.1056/NEJM199903113401004. ISSN 0028-4793. PMID 10072411.
Perfect, John R.; Dismukes, William E.; Dromer, Francoise; Goldman, David L.; Graybill, John R.; Hamill, Richard J.; Harrison, Thomas S.; Larsen, Robert A.; Lortholary, Olivier (2010-02-01). "Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America". Clinical Infectious Diseases. 50 (3): 291–322. doi:10.1086/649858. ISSN 1058-4838. PMC 5826644 . PMID 20047480. Diarsipkan dari versi asli tanggal 2016-05-21.
O'Keeffe, Joseph; Doyle, Sean; Kavanagh, Kevin (2003-12-01). "Exposure of the yeast Candida albicans to the anti-neoplastic agent adriamycin increases the tolerance to amphotericin B". Journal of Pharmacy and Pharmacology. 55 (12): 1629–1633. doi:10.1211/0022357022359. ISSN 2042-7158. PMID 14738588.